Skip to main content
OpenTrials
Completed

NCT Number: NCT01034826

Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP Study

Impaired glucose tolerance is a metabolic state between normal glucose homeostasis and diabetes. Previously, prospective studies have shown higher progression rates from IGT to diabetes in other country. But There is no prospective-multicenter based reports in Korea. Therefore, the purpose of this study is to estimate the progression rates to impair glucose regulation and diabetes in the Korean population-based Korea national Diabetes program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Impaired Glucose Tolerance Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Intolerance Glucose Metabolism Disorders Hyperglycemia Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • fastic serum glucose >100 and/or pp2 serum glucose <200

Exclusion criteria

  • known diabetes
  • organ failure(For example, liver, kidney)
  • known malignancy

Treatment and study plan

Primary outcomes

  1. fasting serum glucose, fasting plasma insulin,post prandial serum glucose, post prandial plasma insulin, hbA1c

    Time frame: 0.1.3.5 year

Sponsors and collaborators

Lead sponsor

Korea University Guro Hospital

Other

Registry information

Important dates

Study start
2007
Primary completion
2009
Study completion
2010
First posted
Dec 18, 2009
Registry last updated
Jun 9, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.